Globus Medical (NYSE: GMED) is one of 67 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its rivals? We will compare Globus Medical to related companies based on the strength of its valuation, analyst recommendations, institutional ownership, profitability, dividends, earnings and risk.
This table compares Globus Medical and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Globus Medical Competitors||-128.68%||-46.53%||-12.33%|
70.2% of Globus Medical shares are held by institutional investors. Comparatively, 66.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 28.2% of Globus Medical shares are held by insiders. Comparatively, 11.8% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Globus Medical and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Globus Medical||$563.99 million||$104.34 million||37.36|
|Globus Medical Competitors||$987.06 million||$131.70 million||229.61|
Globus Medical’s rivals have higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Globus Medical has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Comparatively, Globus Medical’s rivals have a beta of 0.96, suggesting that their average stock price is 4% less volatile than the S&P 500.
This is a summary of recent recommendations and price targets for Globus Medical and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Globus Medical Competitors||204||1142||2424||93||2.62|
Globus Medical currently has a consensus target price of $36.83, indicating a potential downside of 10.38%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.96%. Given Globus Medical’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical has less favorable growth aspects than its rivals.
Globus Medical rivals beat Globus Medical on 8 of the 13 factors compared.
Globus Medical Company Profile
Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.
Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.